Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1596800 VANCOUVER, A1

Position in RDY

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$5,304,217
+$49,719 QoQ
Shares Held
382,976
+2.3% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. RDY ranks #8 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 RDY
Dr Reddys Laboratories Ltd
This page
382,976 $5,304,217

All Filings in RDY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,304,217 382,976
2025-12-31 $5,254,498 374,252
2025-03-31 $419,626 31,814
2024-12-31 $4,826,039 305,639
2024-09-30 $12,352,965 155,481
2024-06-30 $3,709,310 48,685
2024-03-31 $4,386,696 59,805
2023-12-31 $4,460,773 64,110
2023-09-30 $5,192,054 77,644
2023-06-30 $6,468,333 102,493
2023-03-31 $4,014,931 70,524
2022-12-31 $8,558,622 165,384
2022-09-30 $5,665,281 108,240
2022-06-30 $5,852,950 105,668
2022-03-31 $3,838,626 68,879
2021-12-31 $4,873,699 74,510
2021-09-30 $4,412,453 67,738
2021-06-30 $3,463,864 47,121
2021-03-31 $2,818,721 45,915
2020-12-31 $935,396 13,121
2020-06-30 $867,879 16,372
2020-03-31 $1,211,916 30,050